Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Colorectal Neoplasms

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 38 articles:
HTML format



Single Articles


    September 2020
  1. SANFORD NN, Folkert MR, Aguilera TA, Beg MS, et al
    Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016.
    Am J Clin Oncol. 2020 Sep 23. doi: 10.1097/COC.0000000000000764.
    PubMed     Abstract available


  2. BOEHMER U, Clark MA, Ozonoff A, Winter M, et al
    Survivors' Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation.
    Am J Clin Oncol. 2020;43:660-666.
    PubMed     Abstract available


    June 2020
  3. BOEHMER U, Clark MA, Ozonoff A, Winter M, et al
    Survivors' Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation.
    Am J Clin Oncol. 2020 Jun 26. doi: 10.1097/COC.0000000000000732.
    PubMed     Abstract available


    May 2020
  4. SANFORD NN, Aguilera TA, Beg MS, Sanjeevaiah A, et al
    Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015.
    Am J Clin Oncol. 2020;43:311-318.
    PubMed     Abstract available


  5. FRAZER ML, Yang G, Felder S, McDonald J, et al
    Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation.
    Am J Clin Oncol. 2020;43:319-324.
    PubMed     Abstract available


    April 2020
  6. SANFORD NN, Ahn C, Beg MS, Sanjeevaiah A, et al
    Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United States.
    Am J Clin Oncol. 2020 Apr 21. doi: 10.1097/COC.0000000000000698.
    PubMed     Abstract available


  7. BOSMA NA, Tilley D, Batra A, Cheung WY, et al
    Characterizing Urban-Rural Differences in Colon Cancer Outcomes: A Population-based Analysis Based on Travel Distance to Cancer Center.
    Am J Clin Oncol. 2020 Apr 21. doi: 10.1097/COC.0000000000000703.
    PubMed     Abstract available


    March 2020
  8. JIAO X, Hay JW, Sadeghi S, Barzi A, et al
    Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period: A SEER-Medicare Analysis.
    Am J Clin Oncol. 2020 Mar 16. doi: 10.1097/COC.0000000000000684.
    PubMed     Abstract available


    February 2020
  9. ADDO-TABIRI NO, Chudasama R, Vasudeva R, Leiva O, et al
    Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.
    Am J Clin Oncol. 2020;43:94-100.
    PubMed     Abstract available


    January 2020
  10. ZHANG C, Yin S, Tan Y, Huang J, et al
    Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer: A Systematic Review and Meta-Analysis.
    Am J Clin Oncol. 2020 Jan 13. doi: 10.1097/COC.0000000000000663.
    PubMed     Abstract available


  11. APPELT AL, Andersen RF, Lindebjerg J, Jakobsen A, et al
    Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial.
    Am J Clin Oncol. 2020;43:9-13.
    PubMed     Abstract available


    December 2019
  12. LEHRER S, Rheinstein PH
    Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset Colorectal Cancer.
    Am J Clin Oncol. 2019 Dec 23. doi: 10.1097/COC.0000000000000658.
    PubMed     Abstract available


  13. MAHAL AR, Johung KL, Mahal BA, Nguyen PL, et al
    An Update to Changing Patterns of Anal Carcinoma in the United States.
    Am J Clin Oncol. 2019;42:887-897.
    PubMed     Abstract available


    November 2019
  14. PRICOLO VE, Steingrimsson J, McDuffie TJ, McHale JM, et al
    Tumor Deposits in Stage III Colon Cancer: Correlation With Other Histopathologic Variables, Prognostic Value, and Risk Stratification-Time to Consider "N2c".
    Am J Clin Oncol. 2019 Nov 19. doi: 10.1097/COC.0000000000000645.
    PubMed     Abstract available


  15. TAI CC, Chen WS, Jiang JK, Yang SH, et al
    Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2019 Nov 5. doi: 10.1097/COC.0000000000000637.
    PubMed     Abstract available


    September 2019
  16. KOUSTAS E, Sarantis P, Theoharis S, Saetta AA, et al
    Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.
    Am J Clin Oncol. 2019 Sep 11. doi: 10.1097/COC.0000000000000592.
    PubMed     Abstract available


    August 2019
  17. HUO J, Bian J, Xie Z, Hong YR, et al
    Patterns of Postdiagnosis Depression Among Late-Stage Cancer Patients: Do Racial/Ethnic and Sex Disparities Exist?
    Am J Clin Oncol. 2019;42:675-681.
    PubMed     Abstract available


    July 2019
  18. PEABODY J, Rahim A, Wilcox B, McGehee C, et al
    Clinical Utility of a Blood-based Protein Assay on Diagnostic Colonoscopy Referrals for Elevated-risk Colorectal Cancer Patients in Primary Care.
    Am J Clin Oncol. 2019 Jul 19. doi: 10.1097/COC.0000000000000578.
    PubMed     Abstract available


    June 2019
  19. KOENIG JL, Toesca DAS, Harris JP, Tsai CJ, et al
    Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
    Am J Clin Oncol. 2019 Jun 3. doi: 10.1097/COC.0000000000000554.
    PubMed     Abstract available


  20. WEGNER RE, Abel S, Hasan S, White RJ, et al
    Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.
    Am J Clin Oncol. 2019;42:519-526.
    PubMed     Abstract available


    April 2019
  21. ALI ND, Donohue K, Zandieh S, Chen C, et al
    Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living >/=24 Months: A Single Institutional Study.
    Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000535.
    PubMed     Abstract available


    March 2019
  22. LLOYD S, Baraghoshi D, Tao R, Garrido-Laguna I, et al
    Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.
    Am J Clin Oncol. 2019 Mar 5. doi: 10.1097/COC.0000000000000529.
    PubMed     Abstract available


    February 2019
  23. AHMED S, Baig T, Iqbal N, Le D, et al
    Effects of Social and Contextual Factors Including Marital Status and Children on the Use of Palliative Chemotherapy in Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2019 Feb 15. doi: 10.1097/COC.0000000000000530.
    PubMed     Abstract available


    July 2018
  24. CUBILLO A, Alvarez-Gallego R, Munoz M, Pond G, et al
    Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2018 Jul 2. doi: 10.1097/COC.0000000000000474.
    PubMed     Abstract available


    May 2018
  25. CHEN EY, Blanke CD, Haller DG, Benson AB, et al
    A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000465.
    PubMed     Abstract available


    April 2018
  26. BATES JE, Choi G, Usuki KY, Katz AW, et al
    Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.
    Am J Clin Oncol. 2018 Apr 16. doi: 10.1097/COC.0000000000000445.
    PubMed     Abstract available


    March 2018
  27. MCCLURE LA, Sussman DA, Hernandez MN, Tannenbaum SL, et al
    Factors Associated With Receipt of Radiation Therapy for Rectal Cancer.
    Am J Clin Oncol. 2018;41:227-229.
    PubMed     Abstract available


    February 2018
  28. NGUYEN P, Wuthrick E, Chablani P, Robinson A, et al
    Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Am J Clin Oncol. 2018;41:140-146.
    PubMed     Abstract available


  29. DESHMUKH AA, Zhao H, Franzini L, Lairson DR, et al
    Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.
    Am J Clin Oncol. 2018;41:121-127.
    PubMed     Abstract available


    January 2018
  30. LAURENT M, Des Guetz G, Bastuji-Garin S, Culine S, et al
    Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
    Am J Clin Oncol. 2018;41:73-80.
    PubMed     Abstract available


  31. SHANKARAN V, Ortendahl JD, Purdum AG, Bolinder B, et al
    Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States.
    Am J Clin Oncol. 2018;41:65-72.
    PubMed     Abstract available


  32. QIU H, Katz AW, Chowdhry AK, Usuki KY, et al
    Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Am J Clin Oncol. 2018;41:53-58.
    PubMed     Abstract available


    December 2017
  33. CHABLANI P, Nguyen P, Pan X, Robinson A, et al
    Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery.
    Am J Clin Oncol. 2017;40:561-568.
    PubMed     Abstract available


  34. VOONG KR, Rashid A, Crane CH, Minsky BD, et al
    Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
    Am J Clin Oncol. 2017;40:555-560.
    PubMed     Abstract available


  35. OSTI MF, Nicosia L, Agolli L, Gentile G, et al
    Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
    Am J Clin Oncol. 2017;40:535-542.
    PubMed     Abstract available


  36. AHN DH, Wu C, Wei L, Williams TM, et al
    The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Am J Clin Oncol. 2017;40:531-534.
    PubMed     Abstract available


    October 2017
  37. YEOP OH S, Bae Kim Y, Wook Suh K
    Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer.
    Am J Clin Oncol. 2017;40:512-516.
    PubMed     Abstract available


  38. CHARLTON ME, Karlitz JJ, Schlichting JA, Chen VW, et al
    Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.
    Am J Clin Oncol. 2017;40:498-506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: